The Analysis of Consumer Preferences When Choosing Antiarrhythmic Drugs

Vyshemirskaya, E.V.; Ганичева, Л. М.

doi:10.19163/1994-9480-2018-3(67)-67-68

Journal of Volgograd State Medical University

2018

DOI: 10.19163/1994-9480-2018-3(67)-67-68

|View full text |Cite

The Analysis of Consumer Preferences When Choosing Antiarrhythmic Drugs

E.V. Vyshemirskaya¹,

Л. М. Ганичева²

Abstract: ФГБОУ ВО «Волгоградский государственный медицинский университет»Министерства здравоохранения Российской Федерации, кафедра управления и экономики фармации, медицинского и фармацевтического товароведения Выявлены товарные предпочтения потребителей, использующих для лечения назначенные врачом противоаритмические лекарственные препараты (ЛП). Исследования могут быть использованы при формировании рационального ассортимента препаратов исследуемой группы в розничном секторе волгоградского фармацевтического рынка.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Some aspects of pharmacological support with antidysrhythmic drugs

Arkhipov¹,

Bolsunovskaya²

2021

Medical Journal of the Russian Federation

View full text Add to dashboard Cite

A high level of morbidity and mortality from cardiovascular diseases remains prevalent in the Russian Federation, despite a decreasing trend that emerged in recent years. Rhythm and conduction disorders play an essential role in the thanatogenesis of cardiovascular pathology, which determines the medical and social significance of their pharmacotherapy. This is indicated by the stable demand for antidysrhythmic drugs from both the state and the population. This is evidenced by high levels of public procurements and retail sales of drugs for the treatment of cardiovascular diseases, since patients take this drug group for a long time and often permanently. Our marketing analysis of the antidysrhythmic drugs market used current open data from the State Register of Medicines and the State Register of Maximum Selling Prices and available analytical data. It showed that from 54.5% (metoprolol drugs) to 100% (procainamide drugs) of the market share is occupied by generic drugs made in Russia. The presented analysis confirms the assumption of a significant increase in the share of generic drugs in public procurements. This is associated with the implementation of the drug safety program for vital and essential drugs and the optimization of costs by the state. A priority of the state drug policy in Russia is to monitor the effectiveness and safety throughout its entire life cycle. Moreover, particular importance should be given to the issue of interchangeability, which is regulated by Federal Law No. 1360 dated September 5, 2020, On the Procedure for Determining the Interchangeability of Medicines for Medical Use. The annual increase in the share of generic domestic antidysrhythmic drugs on the market poses the problem of selecting the most efficient and safe approach to pharmacotherapy for practicing specialists. The solution may be to develop and implement open automated information systems for the safety profiles of the original and generic antidysrhythmic drugs.

show abstract

Some aspects of pharmacological support with antidysrhythmic drugs

Arkhipov¹,

Bolsunovskaya²

2021

Medical Journal of the Russian Federation

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The Analysis of Consumer Preferences When Choosing Antiarrhythmic Drugs

Cited by 1 publication

References 0 publications

Some aspects of pharmacological support with antidysrhythmic drugs

Some aspects of pharmacological support with antidysrhythmic drugs

Contact Info

Product

Resources

About